| P50 | author | Junichi Sadoshima | Q51313947 |
| | Stephen F Vatner | Q96766914 |
| P2093 | author name string | Jing Liu | |
| | Xianzhong Yu | |
| | Thomas Wagner | |
| | Chull Hong | |
| | Guiping Yang | |
| | Eric Holle | |
| | Mitsutaka Yamamoto | |
| P2860 | cites work | Cancer Research | Q326097 |
| | Inducible cAMP early repressor (ICER) is a negative-feedback regulator of cardiac hypertrophy and an important mediator of cardiac myocyte apoptosis in response to beta-adrenergic receptor stimulation. | Q44468962 |
| | Redox regulation of cell signalling | Q44950052 |
| | Thioredoxin overexpression in transgenic mice | Q48659077 |
| | Thioredoxin and thioredoxin reductase | Q71521704 |
| | Rapamycin selectively inhibits angiotensin II-induced increase in protein synthesis in cardiac myocytes in vitro. Potential role of 70-kD S6 kinase in angiotensin II-induced cardiac hypertrophy | Q71807337 |
| | Upregulation of thioredoxin (TRX) expression in giant cell myocarditis in rats | Q73713267 |
| | Serum thioredoxin (TRX) levels in patients with heart failure | Q74024277 |
| | Inhibitory effects of antioxidants on neonatal rat cardiac myocyte hypertrophy induced by tumor necrosis factor-alpha and angiotensin II | Q77198542 |
| | Intracellular reactive oxygen species mediate the linkage of Na+/K+-ATPase to hypertrophy and its marker genes in cardiac myocytes | Q77927017 |
| | Inhibition of copper-zinc superoxide dismutase induces cell growth, hypertrophic phenotype, and apoptosis in neonatal rat cardiac myocytes in vitro | Q78031799 |
| | Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. | Q24533236 |
| | Demonstration of the interaction of thioredoxin with p40phox, a phagocyte oxidase component, using a yeast two-hybrid system | Q28139055 |
| | Vitamin D3-upregulated protein-1 (VDUP-1) regulates redox-dependent vascular smooth muscle cell proliferation through interaction with thioredoxin | Q28208305 |
| | Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes | Q28241500 |
| | Direct association with thioredoxin allows redox regulation of glucocorticoid receptor function | Q28294971 |
| | Vitamin D(3)-up-regulated protein-1 is a stress-responsive gene that regulates cardiomyocyte viability through interaction with thioredoxin | Q28581284 |
| | Reversible inactivation of the tumor suppressor PTEN by H2O2 | Q29615204 |
| | Phage display identifies thioredoxin and superoxide dismutase as novel protein kinase C-interacting proteins: thioredoxin inhibits protein kinase C-mediated phosphorylation of histone | Q30785404 |
| | Detection, quantitation, purification, and identification of cardiac proteins S-thiolated during ischemia and reperfusion | Q31034023 |
| | Glutathionylation of human thioredoxin: a possible crosstalk between the glutathione and thioredoxin systems | Q31096762 |
| | Reactive oxygen species mediate alpha-adrenergic receptor-stimulated hypertrophy in adult rat ventricular myocytes | Q31763854 |
| | Beta-adrenergic receptor blockade arrests myocyte damage and preserves cardiac function in the transgenic G(salpha) mouse | Q33858191 |
| | Adult T-cell leukemia-derived factor/thioredoxin, produced by both human T-lymphotropic virus type I- and Epstein-Barr virus-transformed lymphocytes, acts as an autocrine growth factor and synergizes with interleukin 1 and interleukin 2 | Q33861934 |
| | Thioredoxin promotes ASK1 ubiquitination and degradation to inhibit ASK1-mediated apoptosis in a redox activity-independent manner | Q34135937 |
| | Redox regulation of cellular activation | Q34425412 |
| | The absence of mitochondrial thioredoxin 2 causes massive apoptosis, exencephaly, and early embryonic lethality in homozygous mice | Q34463545 |
| | Thioredoxin. Overview | Q34566282 |
| | Role of oxidative stress in myocardial hypertrophy and failure | Q34625613 |
| | Reactive oxygen species, mitochondria, and NAD(P)H oxidases in the development and progression of heart failure | Q34667660 |
| | The MEKK1-JNK pathway plays a protective role in pressure overload but does not mediate cardiac hypertrophy. | Q34793636 |
| | Overexpression of thioredoxin in transgenic mice attenuates focal ischemic brain damage | Q36459878 |
| | The MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice | Q40388321 |
| | Distinct roles of thioredoxin in the cytoplasm and in the nucleus. A two-step mechanism of redox regulation of transcription factor NF-kappaB. | Q40928766 |
| | Redox regulatory and anti-apoptotic functions of thioredoxin depend on S-nitrosylation at cysteine 69. | Q42526186 |
| | Transfection with human thioredoxin increases cell proliferation and a dominant-negative mutant thioredoxin reverses the transformed phenotype of human breast cancer cells | Q42806146 |
| | Overexpression of metallothionein reduces diabetic cardiomyopathy. | Q43833575 |
| | The antioxidant N-2-mercaptopropionyl glycine attenuates left ventricular hypertrophy in in vivo murine pressure-overload model | Q43899371 |
| | Overexpression of thioredoxin-1 in transgenic mice attenuates adriamycin-induced cardiotoxicity | Q44131325 |
| | Thioredoxin-dependent redox regulation of p53-mediated p21 activation | Q44275159 |
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | oxidative stress | Q898814 |
| P304 | page(s) | 1395-1406 | |
| P577 | publication date | 2003-11-01 | |
| P1433 | published in | Journal of Clinical Investigation | Q3186904 |
| P1476 | title | Inhibition of endogenous thioredoxin in the heart increases oxidative stress and cardiac hypertrophy | |
| P478 | volume | 112 | |